Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutmeg extract (referred to as NEMM in clinical studies) is an investigational topical botanical preparation developed by researchers at the University of the West Indies, St. Augustine, for the treatment of painful diabetic neuropathy (PDN). The formulation is a complex mixture consisting of nutmeg oil (14%), mace oil (2%), methyl salicylate (6%), menthol (6%), and coconut oil. It was evaluated in a randomized, double-blind, placebo-controlled trial to determine its efficacy in alleviating neuropathic pain. The study concluded that the addition of nutmeg and mace oils to a base containing menthol and methyl salicylate did not provide significant clinical improvements beyond those observed with the control preparation alone over a 4-week treatment period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nutmeg extract (The University of the West Indies).